Ordinary Index Rebalancing in the Enhanced Consciousness Index | March 2022

In the ordinary rebalance the following composition will be implemented effective open 03.03.2022:

ACADIA PHARMACEUTICALS INC
AIKIDO PHARMA INC
ALKERMES PLC
ATAI LIFE SCIENCES B.V
BIOGEN INC
BIOHAVEN PHARMACEUTICAL HOLD
Compass Pathways PLC
DENALI THERAPEUTICS INC
GH RESEARCH PLC
H LUNDBECK AS
INTRA-CELLULAR THERAPIES INC
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
MIND MEDICINE MINDMED INC
MYRIAD GENETICS INC
NEUROCRINE BIOSCIENCES INC
NRX PHARMACEUTICALS INC
RELMADA THERAPEUTICS INC.
SAGE THERAPEUTICS INC
SAREPTA THERAPEUTICS INC
SEELOS THERAPEUTICS INC
TONIX PHARMACEUTICALS HOLDIN
UCB SA
VISTAGEN THERAPEUTICS INC
ZYNERBA PHARMACEUTICALS INC